Jim is recognized as one of the World’s Leading IP Strategists by Intellectual Asset Magazine in its annual IAM 300 publication. In addition to being a seasoned trial lawyer who skillfully represents clients in federal and state courts nationwide, the U.S. International Trade Commission, and U.S. Circuit Courts of Appeal, including the Federal Circuit. Jim leverages this intersection between his sophisticated commercial litigation background and intellectual property experience to advise clients on global licensing and enforcement strategies. Jim is a well-respected voice in the worldwide dialogue concerning standard essential patents (SEPs) and the rapidly evolving landscape of global competition and patent law that impacts SEP value and licensing opportunities.
Jim’s experience includes litigating patent, trade secrets, and trademark cases through trial and appeal. This experience spans a wide range of diverse technologies, from semiconductors, graphics processors, core processors, telecommunications infrastructure, advanced memory modules, quantum dots, LED lighting systems, and medical devices.
According to the editors of IAM Magazine in its "Patent 1000" publication, James Wodarski is “a leading light on SEPs” and “also brings the heat in ITC matters”.
A versatile trial lawyer, Jim has more than 25 years of complex civil litigation experience, and has represented clients in a broad spectrum of disputes, including complex business litigation, white collar crime, insurance coverage, federal securities actions, trademark ownership of mass media and literary titles, complex insurance coverage, and First Amendment issues. Before entering private practice, he also served as an assistant district attorney in Hampden Country, Massachusetts.
- Vanderbilt University (JD)
- George Washington University (BA)
Federal Circuit Appeals
- Preservation Wellness Technologies LLC v. NextGen Healthcare Information Systems LLC, et al, 2016-2193, 2016-2194, 2016-2195 (Fed. Cir.) - Successfully argued at the Court of Appeals for the Federal Circuit to affirm an Eastern District of Texas ruling from May 2016 that held unpatentable a medical records patent asserted by Preservation Wellness against long-time client NextGen Healthcare. Mintz also argued on behalf of co-appellees Allscripts Healthcare Solutions Inc. and Epic Systems Corp. NextGen Healthcare provides electronic health record, financial, and health information exchange solutions for myriad healthcare organizations and the infringement allegations threatened “Patient Portal,” a key component of the company’s service.
International Trade Commission
- Certain Flocked Swabs, Products Containing Flocked Swabs, And Methods of Using Same (337-TA-1279) - Representing Copan Italia and Copan Industries as complainants in the International Trade Commission, asserting patent infringement claims against global competitors in a case involving the use of flocking technology (common in the textile industry) in the production of biological specimen collection swabs.
- Certain Thermoplastic-Encapsulated Electric Motors, Components Thereof, and Products and Vehicles Containing Same (337-TA-1052) – Represented complainant, owner of an innovative electric motor patents with wide applications in the automotive industry, in this ITC investigation and in related parallel Federal District Court cases.
- Certain Graphics Systems, Components Thereof, and Consumer Products Containing the Same (337-TA-1044) – Represented Advanced Micro Devices (AMD) as complainant in the ITC asserting patents covering graphics processing technology employed by smart devices such as televisions and handsets. Respondents include LG Electronics, VIZIO, MediaTek, and Sigma Designs, Inc. (SDI). Achieved settlement with LG prior to the conclusion of expert discovery. Following the evidentiary hearing, the presiding ALJ issued an initial determination finding a violation of Section 337 and recommending the imposition of an exclusion order against the remaining Respondents’ accused products. The ITC affirmed the ALJ’s finding of a violation on August 22, 2018. As a result, the Commission issued orders banning the importation of products made by VIZIO, MediaTek, and SDI and cease and desist orders against VIZIO and SDI.
- Certain Computing or Graphics Systems, Components Thereof, and Vehicles Containing Same (337-TA-984) – Represented owner of portfolio of graphics processing and microprocessor patents, Advanced Silicon Technologies, LLC, as Complainant in an ITC investigation adverse to a number of automotive manufacturers, and infotainment system and chip suppliers. Respondents include Honda, Toyota, BMW, Audi, Volkswagen, NVIDIA, Texas Instruments, Renesas, Harman International, and Fujitsu-Ten. The investigation instituted in January of 2016 and resolved favorably prior to the conclusion of expert discovery in August of 2016.
Federal District Court
- Copan Italia SpA et al v. Puritan Medical Products Company LLC et al, 1:18-cv-00218 (D. Me) - Representing Copan Italia in asserting patent infringement and unfair competition claims against our client’s largest competitor, in a case involving the use of flocking technology (common in the textile industry) in the production of swabs to be used for the collection of biological specimen.
- Nanoco Technologies Ltd. v. Samsung Electronics Co., Ltd., et al., (E.D. Tex, 2:20-cv-00038-JRG) - Representing Nanoco Technologies, Ltd. v. Samsung Electronics Co., Ltd. et al in a patent infringement case involving the synthesis of quantum dots, and use of quantum dot film resins in electronic display devices. Jury selection is scheduled for October 4, 2021.
- CellInfo, LLC v. American Tower Corporation, et al., (D. Mass., 1:18-cv-11250) – Successfully defended American Tower Corporation in a trade secrets action in arbitration and federal district court.
- Netlist Inc. v. SK hynix Inc., et al., (W.D. Tex, 6:20-cv-194-ADA, 6:20-cv-525-ADA) - Represent plaintiff Netlist, Inc. in asserting three patents essential to JEDEC DDR4 RDIMM and LRDIMM standards against the Korean-based memory company, SK hynix in the Western District of Texas. Trial is scheduled for October of 2021.
Trade Secrets Litigation
- Railrunner N.A., Inc. v. Virgil E. Duncan and Duncan Family, LLC, et al., 00-3003 (Middlesex Superior Court) – Represented the plaintiff against its original founder and ousted-CEO in bringing a trade secret complaint related to the founder’s attempted use of trade secrets concerning to the company’s intermodal rail technology. It involved federal court/state court, and arbitration proceedings.
Recognition & Awards
- Identified in the IAM Patent 1000, a listing of the “World’s Leading Patent Practitioners” (2020 - 2021)
- Recognized by The Legal 500 United States for Intellectual Property: Patent Litigation - International Trade Commission (2017 - 2018, 2021)
- Recognized among the most active International Trade Commission Section 337 practitioners (2021) by Patexia in its annual survey
- Selected for the 2020 & 2021 editions of IAM Strategy 300 – The World's Leading IP Strategists
- Included on the Massachusetts Super Lawyers: Intellectual Property Litigation list (2014 – 2020)
December 7, 2020 |Blog
News & Press
December 7, 2020 | Blog | By Michael Renaud, James Wodarski, Matthew Galica
The Art of An SEP War: A Chinese IP Court’s Recent Use of Anti-Suit Injunction Invites A Battle that It Likely Won’t Win
October 26, 2020 | Blog | By Michael Renaud, James Wodarski, Daniel Weinger
September 14, 2020 | Blog | By Michael Renaud, James Wodarski, Joseph Miller, Daniel Weinger, Kara E. Grogan
August 26, 2020 | Blog | By Michael Renaud, James Wodarski, Daniel Weinger, Matthew Galica
The Standard Does Rule Them All: Federal Circuit Panel Finds Standard Sufficient to Prove Infringement for SEP Compliant Products
August 5, 2020 | Blog | By Michael Renaud, James Wodarski, Daniel Weinger, Kara E. Grogan
IT TAKES TWO TO TANGO: The German Federal Supreme Court Acknowledges That Infringer Hold-Out is a Real Problem
July 16, 2020 | Blog | By Michael Renaud, James Wodarski, Matthew Galica
The Standard May Rule Them All: Federal Circuit Panel Appears Prepared to Find Standard Is Sufficient to Prove Infringement for SEP Compliant Products
July 9, 2020 | Blog | By Michael Renaud, James Wodarski, Daniel Weinger, Kara E. Grogan
Actions Speak Louder Than Words: Germany’s Highest Court tells SEP implementers that simply saying that you are willing to license is not enough, and hold-out will not be tolerated
May 12, 2020 | Blog | By Michael Renaud, James Wodarski, Matthew Galica
January 6, 2020 | Blog
Out with the old, and in with the new: joint policy statement and recent cases confirm that injunctive relief on standard-essential patents is available at the ITC
December 23, 2019 | Blog | By Michael Renaud, James Wodarski, Andrew DeVoogd, Matthew Galica
News & Press
September 20, 2021
December 22, 2020
November 9, 2020
A Critique of Glory Days and How Reports of Anticompetitive Risks of Pools Have Been Greatly Exaggerated
November 4, 2020
November 2, 2020
September 24, 2020
Joint Policy Statement and Recent Cases Confirm That Injunctive Relief on SEPs is Available at the ITC
March 19, 2020
December 16, 2019
October 30, 2019
October 22, 2019
The article noted that the Mintz team representing Netlist includes Member and Chair of the Intellectual Property Division Michael Renaud, along with Members James Wodarski, Drew DeVoogd, Steve Akerley, Aarti Shah, and Associates Kristina Cary, Matthew Galica, and Tiffany Knapp.
September 18, 2019
The Mintz team representing Glycosyn at the ITC includes Michael Newman, Thomas Wintner, Michael Renaud and James Wodarski; and the Mintz team representing Glycosyn at the PTAB includes Michael Newman, Thomas Wintner, Peter Cuomo and Daniel Weinger.
In a precedential opinion, the Federal Circuit affirmed decisions upholding the validity of nearly a dozen Elm patents on semiconductor technologies that accused infringers challenged at the Patent Trial and Appeal Board.
The Mintz team representing Elm includes Member and Chair of the firm’s Intellectual Property Division Michael Renaud, Members William Meunier, James Wodarski and Michael Newman, Special Counsel Sandra Badin, and Associates Kevin Amendt and Matthew Galica.